135 results on '"Parana, Raymundo"'
Search Results
2. Stanozolol-induced Liver Injury: A Distinctive Cholestatic Clinical and Biochemical Phenotype at Presentation
3. Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network
4. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
5. Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review
6. Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil
7. Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
8. Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B
9. WED-185 Frequency of ATP8B1, ABCB11 and ABCB4 gene mutations in adult patients with idiopathic chronic cholestasis
10. Serious liver injury induced by Nimesulide: an international collaborative study
11. Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil
12. Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
13. OP- 10 - NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A COMPARATIVE ANALYSIS BETWEEN THE SPANISH AND LATINDILI NETWORKS
14. P-35 CLINICAL AND EPIDEMIOLOGICAL DIFFERENCES BETWEEN PATIENTS MONOINFECTED WITH HEPATITIS B AND COINFECTED WITH HEPATITIS DELTA IN A HYPERENDEMIC REGION OF HEPATITIS B
15. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis
16. Hepatitis D Virus
17. OP-1 FEATURES OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) IN LATIN AMERICA: LONG-TERM EXPERIENCE OF THE LATINDILI NETWORK
18. Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin
19. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries
20. O-39 CLINICAL CHARACTERISTICS AND OUTCOME OF DRUG-INDUCED LIVER INJURY DUE TO ANTINEOPLASTIC AND BIOLOGICAL AGENTS
21. Chronic HDV/HBV co-infection: Predictors of disease stage – a case series of HDV-3 patients
22. Serum levels of immunoglobulin free light chains in patients with chronic hepatitis C presenting cryoglobulinemia
23. Serotonin-1A receptor CC genotype is associated with persistent depression related to interferon-alpha in hepatitis C patients
24. O-37 AMOXICILLIN-CLAVULANATE INDUCED LIVER INJURY: TEN YEARS EXPERIENCE FROM LATINDILI REGISTRY.
25. O-17 STUDY OF THE ASSOCIATION BETWEEN SERUM LEVELS OF SYSTEMIC INFLAMMATORY MARKERS AND ADVANCED FIBROSIS STAGE IN INFECTED PATIENTS WITH HEPATITIS DELTA VIRUS GENOTYPE 3
26. Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Patients With Chronic Hepatitis C
27. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection
28. Hepatitis B virus prevalence and vaccination response in health care workers and students at the Federal University of Bahia, Brazil
29. Prevalence of non-organ-specific autoantibodies in a rural community from northeastern Brazil: a population-based study
30. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C
31. Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
32. Epidemiological assessment of liver disease in northeastern Brazil by means of a standardized liver biopsy protocol
33. Autoimmunity in hepatitis C virus carriers: Involvement of ferritin and prolactin
34. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies
35. O-28 DRUG-INDUCED LIVER INJURY IN LATINAMERICA: First ten years’ experience of the ongoing LATINDILI Network
36. P-50 PREVALENCE OF HEPATITIS AMONG STUDENTS AND HEALTH PROFESSIONALS AT THE FEDERAL UNIVERSITY OF BAHIA
37. P-12 QUALITATIVE EVALUATION OF NATURAL PRODUCTS USED BY PATIENTS IN A BRAZILIAN HEPATOTOXICITY AMBULATORY
38. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver
39. IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections
40. Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
41. Impact of psychiatric disorders on the quality of life of Brazilian HCV-infected patients
42. Serious liver injury induced by Nimesulide: an international collaboration study reporting 57 cases
43. Hepatotropic viruses in the Brazilian Amazon: a health threat
44. Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review
45. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy
46. Profile of herbal and dietary supplements induced liver injury in Latin America: A systematic review of published reports
47. HBV epidemiology in Latin America
48. Acute dystonia after injection of pegylated interferon alpha-2b
49. Peripheral Insulin Resistance During Treatment of Chronic Hepatitis C With Peguilated Interferon Plus Ribavirin
50. Non-alcoholic steatohepatitis: is the aminotransferase ratio (AST/ALT > 1) related with fibrosis?: OP-37
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.